Bio Green Med Solution, Inc. — Director's Dealing 2010

Mar 31, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2010-03-29

Reporting Person: UPRICHARD DAVID C (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-03-29	Option	$2.38	A	50000	Acquired	2020-03-29	Common Stock (50000)	Direct

Footnotes

F1: These options are exercisable over a four-year period with one-fourth (1/4) of the options vesting on the first anniversary of the grant date and the balance vesting ratably on a monthly basis over the 36 months following thereafter.

F2: The options were granted to Mr. U'Prichard for his services as the chairman of the board of directors of Cyclacel Pharmaceuticals, Inc.